Use of 2-hydroxyethoxy amide acid - (6 - 4-bromo-2 - fluorofenilamini) - 5 - fluoro - 3 - methyl - 3 - 5 - served carboxylic acid for the treatment of Noonan syndrome and a Pharmaceutical composition； Packaging；
The use of a MEK inhibitor compound of Formula (I), as defined herein, or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment of Noonan Syndrome, a method of treating a warm-blooded animal, especially a human, having Noonan Syndrome, comprising administering to said animal a therapeutically effective amount of a MEK inhibitor compound of Formula (I), as defined herein, or a pharmaceutically acceptable salt thereof； and to a pharmaceutical composition and a commercial package comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and a package insert or other labeling including directions for treating Noonan Syndrome.USO DE 2-HIDROXIETOXI-AMIDA DEL ÁCIDO 6-(4-BROMO-2-FLUOROFENILAMINO)-7-FLUORO-3-METIL-3H-BENZOIMIDAZOL-5-CARBOXÍLICO PARA EL TRATAMIENTO DEL SÍNDROME DE NOONAN, COMPOSICIÓN FARMACÉUTICA Y ENVASE QUE COMPRENDEN A DICHO COMPUESTO.
